Fourth Question of the Day October 10, 2013 Do Compounding Pharmacies that advertise short-dated compounds for sale provide evidence to the FDA and states boards of pharmacy that they are manufacture-ing drugs in excess of previous patient demand and compound drugs without prescriptions?

* QUALITY BEYOND REPROACH    * COMPETITIVE PRICING    * EXCELLENT CUSTOMER SERVICE    * PROGRESSIVE COMPOUNDS    * USP 795/797 COMPLIANT Short-Dated Compounds Promotion Save Now on Compounds that are Short-Dated! Quantities are limited and back-orders cannot be taken. Must mention code NVSD13 in order to receive the special pricing.    Short Dated Compounds List    Call Today to Order!     Would you like to see our latest price sheet and catalogs? NuVision Pharmacy 800-914-7435 214-347-4008 www.nuvisionpharmacy.com    A Truly Unique Compounding Pharmacy!

NuVision Website Indicates that it continues to improve our facility and incorporate safety measures that would surpass the requirements of current regulation, including changes based on the FDA’s recommendations.

and it provides access to historical test data but does not provide a name of lab that preforms its test.  View here

IMMEDIATE!! URGENT!! FDA reminds health care providers not to use sterile products from NuVision Pharmacy Products may still pose serious risk to patients

For Immediate Release: Aug. 16, 2013
Media Inquiries: Christopher Kelly, 301-796-4676 christopher.kelly@fda.hhs.gov

Consumer Inquiries: 888-INFO-FDA                                   

 

The U.S. Food and Drug Administration is reminding health care providers about safety concerns with all sterile drug products made and distributed by NuVision Pharmacy of Dallas, Texas. Health care providers should not administer any NuVision Pharmacy sterile products to patients because the products’ sterility is not assured.

 

This alert follows the FDA’s notice on May 18, 2013 recommending that health care providers and other health care professionals, including hospital staff, immediately check their medical supplies for NuVision Pharmacy sterile products, quarantine those products, and not administer them to patients.

 

NuVision Pharmacy has repeatedly declined to recall its sterile products. The FDA most recently issued a letter to NuVision on July 26, 2013, requesting an immediate recall of all lots of sterile products that have not passed their expiration dates produced at NuVision. In the letter, the FDA outlined poor sterile production practices observed by FDA investigators during an April 2013 inspection of NuVision’s Dallas facility. The FDA explained that those practices raised concerns about a lack of sterility assurance of NuVision’s sterile drug products. The FDA noted that if a drug product marketed as sterile contains microbial contamination, patients could be at risk for serious, potentially life-threatening infections.

 

NuVision responded to the letter by refusing to recall its sterile products. Under its authority, the FDA cannot require NuVision to undertake such a recall. Therefore the agency reminds health care providers not to use any sterile products from NuVision.

 

In April 2013 NuVision recalled methylcobalamin injection and lyophilized injection products due to a lack of sterility assurance and concerns associated with the quality control processes identified during the FDA’s April 2013 inspection. The FDA received adverse event reports of fever, flu-like symptoms, and soreness at the injection site associated with the methylcobalamin injection product that was previously recalled. The agency is not aware of any adverse event reports associated with other sterile products from NuVision.

 

Patients who were administered any sterile drug product produced and distributed by NuVision and who have concerns should contact their health care provider. The FDA asks health care providers and consumers to report adverse reactions or quality problems experienced with the use of any NuVision product to the FDA’s MedWatch Adverse Event Reporting program by:

• completing and submitting the report online at www.fda.gov/medwatch/report.htm; or  
• downloading and completing the form, then submitting it via fax to 1-800-FDA-0178.

 

The FDA, an agency within the U.S. Department of Health and Human Services, protects public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices.  The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.